AcuFocus Inc. is a finalist in the 2012 Medical Design Excellence Awards (MDEA) for its proprietary corneal inlay (Kamra).
Irvine, CA-AcuFocus Inc. is a finalist in the 2012 Medical Design Excellence Awards (MDEA) for its proprietary corneal inlay (Kamra).
The inlay is designed to reverse the effects of presbyopia and restore near and immediate vision. It is currently an investigational device in the United States.
The MDEA recognize contributions and advances in the design of medical products. Entries are evaluated based on their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.
“We’re excited to be recognized by the MDEA for our ongoing accomplishments in the medical device industry,” said Ed Peterson, chief executive officer of AcuFocus. “[The proprietary inlay] is the product of boundless hard work and innovation by our entire team, which includes clinical input from surgeons around the world. In light of the ongoing acceptance of the inlay globally, with [more than] 10,000 patients today [having received the implants] and high patient satisfaction, to be [also] chosen as a finalist for this esteemed award is a great honor.”
The winners will be announced May 23. For more information on the awards, visit www.MDEAwards.com.
For more articles in this issue of Ophthalmology Times eReport, click here.